Choices and Experiences Around Closed-loop Therapy in Type 1 Diabetes

Summary

Type 1 diabetes requires a lot of work to try to keep glucose levels in the target range. Hybrid closed- loop, also known as artificial pancreas, takes glucose readings from a sensor (continuous glucose monitor) and uses an algorithm to tell an insulin pump how much insulin to deliver. Hybrid closed-loop has currently been rolled out to many people with type 1 diabetes in England. We are keen to develop a deeper understanding of the perspective of people living with type 1 diabetes who have choices about which hybrid closed-loop systems fit their needs. The main purpose of this study is to explore the choices and experiences of people living with type 1 diabetes regarding closed-loop therapy.

Eligibility

Inclusion Criteria:

* Age: ≥18 years (no upper age limit)
* Type 1 diabetes (any duration)
* People who use closed-loop therapy or wait to start closed-loop therapy or considering closed-loop therapy in the future
* Ability to give informed consent

Exclusion Criteria:

* Any other type of diabetes apart from type 1 diabetes

Conditions3

Browse More Trials